Table 1 Hypertension Medicines Availability. Drugs and formulations prescribed to patients with hypertension, its estimated need and availability in the hospital
Therapeutic Group | Generic Name / International Nonproprietary Name | Pharmaceutical form | Strength | Posology | Estimated need for one month | % of medicines available | SDG EM Target Availability |
|---|---|---|---|---|---|---|---|
Thiazide diuretic + potassium sparing diuretic | Hydrochlorothiazide Amiloride | Tablets | 50 mg + mg | 0,5 | 7905 | 0% | < 80% |
Angiotensin Converting Enzyme Inhibitor | Lisinopril | Tablets | 20 mg | 1 | 15,810 | 0% | < 80% |
Calcium Channel Antagonists | Nifedipine | Tablets | 30 mg | 1 | 15,810 | 145% | > 80% |
Calcium Channel Antagonists | Nifedipine | Tablets | 60 mg | 1 | 15,810 | 0% | < 80% |
Beta blocker | Bisoprolol | Tablets | 5 mg | 1 | 15,810 | 0% | < 80% |
Beta blocker | Atenolol | Tablets | 50 mg | 0,5 | 7905 | 0% | < 80% |
Angiotensin-II Receptor Antagonist | Irbesartan | Tablets | 300 mg | 1 | 15,810 | 0% | < 80% |
Angiotensin Converting Enzyme Inhibitor | Enalapril | Tablets | 20 mg | 1 | 15,810 | 60% | < 80% |
Adrenergic modifier / alpha 2 agonist | Methyldopa | Tablets | 250 mg | 1 | 15,810 | 51% | < 80% |
Aldosterone antagonist | Spironolactone | Tablets | 25 mg | 1 | 15,810 | 6% | < 80% |
Loop diuretic | Furosemide | Tablets | 40 mg | 1 | 15,810 | 70% | < 80% |